Recent updates

  • 30 Oct 2019EMA’s safety committee recommends a 4-week limit for use of high-strength estradiol creamsTopic: Urinary tract infections in women
  • 30 Oct 2019EMA’s safety committee recommends a 4-week limit for use of high-strength estradiol creamsTopic: Menopause
  • 22 Oct 2019FDA warns direct-acting antivirals can cause serious liver injury in patients with advanced liver diseaseTopic: Hepatitis C
  • 13 Sep 2019FDA approves liraglutide for use in children ≥10 years with type 2 diabetesTopic: Type 2 diabetes in children
  • 03 Sep 2019Experimental Ebola drugs reduce mortalityTopic: Ebola virus infection
  • 11 Jul 2019US FDA approves brexanolone, the first drug approved specifically to treat postpartum depressionTopic: Postpartum depression
  • 05 Jul 2019EMA recommends restricting fluoroquinolone antibiotics to serious or life-threatening bacterial infections onlyTopic: Urinary tract infections in children
  • 09 May 2019No new patients should start treatment with olaratumabTopic: Soft-tissue sarcoma
  • 08 May 2019Comprehensive network meta-analysis provides guidance to inform choice of medication in GADTopic: Generalized anxiety disorder
  • 09 Apr 2019Intravenous artesunate now first-line treatment for severe malaria in the USTopic: Malaria infection
  • 14 Nov 2018First-in-class treatment approved in the US for relapsed or refractory hairy cell leukemiaTopic: Hairy cell leukemia
  • 20 Sep 2018CDC alerts clinicians to a 'dramatic rise' in overdose deaths from fentanyl and its analogsTopic: Opioid overdose
  • 13 Jul 2018European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancyTopic: Bipolar disorder in children